| Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial A Bastidas, J De La Serna, M El Idrissi, L Oostvogels, P Quittet, ... Jama 322 (2), 123-133, 2019 | 224 | 2019 |
| Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy … AF Dagnew, O Ilhan, WS Lee, D Woszczyk, JY Kwak, S Bowcock, ... The Lancet infectious diseases 19 (9), 988-1000, 2019 | 208 | 2019 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 106 | 2023 |
| Long‐term follow‐up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy F Palandri, L Catani, N Testoni, E Ottaviani, N Polverelli, M Fiacchini, ... American journal of hematology 84 (4), 215-220, 2009 | 85 | 2009 |
| Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP M Baccarani, E Abruzzese, V Accurso, F Albano, M Annunziata, S Barulli, ... Blood advances 3 (24), 4280-4290, 2019 | 82 | 2019 |
| Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis ST Oh, RA Mesa, CN Harrison, P Bose, AT Gerds, V Gupta, BL Scott, ... Blood Advances 7 (19), 5835-5842, 2023 | 51 | 2023 |
| Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations F Zaja, M Carpenedo, C Baratè, A Borchiellini, F Chiurazzi, G Finazzi, ... Blood Reviews 41, 100647, 2020 | 40 | 2020 |
| Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report A Casadei Gardini, E Chiadini, L Faloppi, G Marisi, A Delmonte, ... BMC cancer 16, 1-5, 2016 | 39 | 2016 |
| IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia G Musuraca, S De Matteis, R Napolitano, C Papayannidis, ... Journal of translational medicine 13, 1-10, 2015 | 36 | 2015 |
| Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia L Gugliotta, A Tieghi, G Tortorella, PR Scalzulli, R Ciancia, M Lunghi, ... Leukemia research 35 (12), 1557-1563, 2011 | 35 | 2011 |
| Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients S De Matteis, C Molinari, G Abbati, T Rossi, R Napolitano, M Ghetti, ... Journal of translational medicine 16, 1-9, 2018 | 33 | 2018 |
| ACE2 and TMPRSS2 potential involvement in genetic susceptibility to SARS-COV-2 in cancer patients S Ravaioli, M Tebaldi, E Fonzi, D Angeli, M Mazza, F Nicolini, A Lucchesi, ... Cell transplantation 29, 0963689720968749, 2020 | 29 | 2020 |
| Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study M Napolitano, L Valore, A Malato, G Saccullo, C Vetro, ME Mitra, ... Leukemia & Lymphoma 57 (1), 116-119, 2016 | 29 | 2016 |
| COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report M Breccia, E Abruzzese, V Accurso, I Attolico, S Barulli, M Bergamaschi, ... British Journal of Haematology 196 (3), 559-565, 2022 | 28 | 2022 |
| Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial AC Gardini, S Carloni, E Scarpi, P Maltoni, RM Dorizzi, A Passardi, ... Oncotarget 7 (9), 10193, 2016 | 26 | 2016 |
| Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease A Casadei Gardini, M Aquilina, D Oboldi, A Lucchesi, S Carloni, E Tenti, ... BMC cancer 13, 1-5, 2013 | 25 | 2013 |
| Genetics and pathogenetic role of inflammasomes in Philadelphia negative chronic myeloproliferative neoplasms: a narrative review V Di Battista, MT Bochicchio, G Giordano, M Napolitano, A Lucchesi International Journal of Molecular Sciences 22 (2), 561, 2021 | 24 | 2021 |
| Phase 1 trial of vodobatinib, a novel oral BCR-ABL1 tyrosine kinase inhibitor (TKI): activity in CML chronic phase patients failing TKI therapies including ponatinib JE Cortes, T Saikia, DW Kim, Y Alvarado, FE Nicolini, N Khattry, ... Blood 136, 51-52, 2020 | 24 | 2020 |
| Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report A Casadei Gardini, M Mariotti, A Lucchesi, S Pini, M Valgiusti, ... BMC cancer 16, 1-4, 2016 | 24 | 2016 |
| Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice EA Stadtmauer, KM Sullivan, M El Idrissi, B Salaun, A Alonso Alonso, ... Human vaccines & immunotherapeutics 17 (11), 4144-4154, 2021 | 23 | 2021 |
Giovanni MartinelliProfessor of Hematology "L. e A. Seragnoli" InstituteVerified email at unibo.it